Original Research
Published on 12 Feb 2013
Monitoring Response and Resistance to the Novel Arsenical Darinaparsin in an AML Patient
in Pharmacology of Anti-Cancer Drugs
Frontiers in Pharmacology
doi 10.3389/fphar.2013.00009
- 6,675 views
- 5 citations